Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,728,352,485
-$374,828,445 QoQ
Shares Held
2,771,839
+1.8% QoQ
Ownership
2.69%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#8
of 1,321 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. REGN ranks #1 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,728,352,485 | 2,771,839 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,103,180,930 | 2,722,071 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,975,990,281 | 2,560,004 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,379,328,710 | 2,453,143 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,214,585,400 | 2,313,496 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,443,935,579 | 2,276,675 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,456,864,435 | 2,045,210 | Shares | Defined | 2025-02-12 | |
| 2024-06-30 | $2,021,237,889 | 1,923,102 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,630,744,877 | 1,694,298 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $425,191,603 | 484,113 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $397,662,496 | 483,210 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $351,124,627 | 488,664 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $402,440,815 | 489,784 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $363,250,728 | 503,473 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $362,481,321 | 526,197 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $310,157,629 | 524,686 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $393,741,254 | 563,760 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $399,403,555 | 632,448 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $366,525,446 | 605,647 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $342,264,928 | 612,785 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $279,154,486 | 590,004 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $297,686,580 | 616,188 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $403,342,197 | 720,537 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $432,653,442 | 693,744 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $284,607,145 | 582,865 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||